NSF-MR-Contrastmedia - Introduction

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

NSF-MR-Contrastmedia - Introduction. / Marckmann, P.; Thomsen, Henrik S.

I: European Journal of Radiography, Bind 66, Nr. 2, 2008, s. 153-159.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Marckmann, P & Thomsen, HS 2008, 'NSF-MR-Contrastmedia - Introduction', European Journal of Radiography, bind 66, nr. 2, s. 153-159.

APA

Marckmann, P., & Thomsen, H. S. (2008). NSF-MR-Contrastmedia - Introduction. European Journal of Radiography, 66(2), 153-159.

Vancouver

Marckmann P, Thomsen HS. NSF-MR-Contrastmedia - Introduction. European Journal of Radiography. 2008;66(2):153-159.

Author

Marckmann, P. ; Thomsen, Henrik S. / NSF-MR-Contrastmedia - Introduction. I: European Journal of Radiography. 2008 ; Bind 66, Nr. 2. s. 153-159.

Bibtex

@article{f1761370873411de8bc9000ea68e967b,
title = "NSF-MR-Contrastmedia - Introduction",
abstract = "Until recently it was believed that extracellular gadolinium based contrast agents (Gd-CA) were safe for both the kidneys and all other organs within the dose range up to 0.3 mmol/kg body weight. However, in 2006, it was demonstrated that some Gd-CA may trig the development of nephrogenic systemic fibrosis, a generalized fibrotic disorder, in renal failure patients. This sub-section of European Journal of Radiology covers the current knowledge about NSF from many aspects. The prevention of NSF must be given high priority, but it should not lead to a denial of a well-justified, enhanced MRI examination with a stable agent. (C) 2008 Elsevier Ireland Ltd. All rights reserved Udgivelsesdato: 2008/5",
author = "P. Marckmann and Thomsen, {Henrik S.}",
note = "Times Cited: 0Editorial MaterialEnglishThomsen, H. SCopenhagen Univ Hosp, Dept Diagnost Radiol 54E2, Herlev Ringvej 75, DK-2730 Herlev, DenmarkCited References Count: 20304WXELSEVIER IRELAND LTDELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELANDCLARE",
year = "2008",
language = "English",
volume = "66",
pages = "153--159",
journal = "European Journal of Radiography",
issn = "1756-1175",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - NSF-MR-Contrastmedia - Introduction

AU - Marckmann, P.

AU - Thomsen, Henrik S.

N1 - Times Cited: 0Editorial MaterialEnglishThomsen, H. SCopenhagen Univ Hosp, Dept Diagnost Radiol 54E2, Herlev Ringvej 75, DK-2730 Herlev, DenmarkCited References Count: 20304WXELSEVIER IRELAND LTDELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELANDCLARE

PY - 2008

Y1 - 2008

N2 - Until recently it was believed that extracellular gadolinium based contrast agents (Gd-CA) were safe for both the kidneys and all other organs within the dose range up to 0.3 mmol/kg body weight. However, in 2006, it was demonstrated that some Gd-CA may trig the development of nephrogenic systemic fibrosis, a generalized fibrotic disorder, in renal failure patients. This sub-section of European Journal of Radiology covers the current knowledge about NSF from many aspects. The prevention of NSF must be given high priority, but it should not lead to a denial of a well-justified, enhanced MRI examination with a stable agent. (C) 2008 Elsevier Ireland Ltd. All rights reserved Udgivelsesdato: 2008/5

AB - Until recently it was believed that extracellular gadolinium based contrast agents (Gd-CA) were safe for both the kidneys and all other organs within the dose range up to 0.3 mmol/kg body weight. However, in 2006, it was demonstrated that some Gd-CA may trig the development of nephrogenic systemic fibrosis, a generalized fibrotic disorder, in renal failure patients. This sub-section of European Journal of Radiology covers the current knowledge about NSF from many aspects. The prevention of NSF must be given high priority, but it should not lead to a denial of a well-justified, enhanced MRI examination with a stable agent. (C) 2008 Elsevier Ireland Ltd. All rights reserved Udgivelsesdato: 2008/5

M3 - Journal article

VL - 66

SP - 153

EP - 159

JO - European Journal of Radiography

JF - European Journal of Radiography

SN - 1756-1175

IS - 2

ER -

ID: 13708761